Oncternal TherapeuticsONCT
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 26 institutions reported holding Oncternal Therapeutics Inc. (ONCT) in their 13F filings, up 2 from Q1 2024. 4 opened new positions and 2 sold out. The largest holders were Vanguard Group Inc. ($1.1M), Millennium Management ($782K) and BlackRock Inc. ($299K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Oncternal Therapeutics Inc.
- CUSIP
- 68236P206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $191K |
| Exits | 2 | $22K |
All 13F filers, Q1 2024 → Q2 2024: 36,979 shares bought and 3,879 shares sold, net +33,100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | No change | 143,043 | $1.1M |
| Millennium Management | 0.00% | Reduce -0.1% | 102,936 | $782K |
| BlackRock Inc. | 0.00% | No change | 39,278 | $299K |
| Quantum Private Wealth, LLC | 0.07% | Reduce -3.3% | 26,902 | $204K |
| Dimensional Fund Advisors LP | 0.00% | Add +1.6% | 26,298 | $200K |
| Geode Capital Management, LLC | 0.00% | Add +7.5% | 25,879 | $197K |
| Pasadena Private Wealth, LLC | 0.04% | New | 25,000 | $190K |
| Richmond Brothers, Inc. | 0.37% | No change | 24,696 | $188K |
| Renaissance Technologies | 0.00% | Add +1.8% | 17,205 | $131K |
| Brighton Jones LLC | 0.00% | No change | 16,923 | $129K |
| Susquehanna International Group, LLP | 0.00% | Add +49.2% | 15,206 | $116K |
| Morgan Stanley | 0.00% | Add +39.5% | 15,067 | $115K |
| Acadian Asset Management LLC | 0.00% | Reduce -6.2% | 1,829 | $13K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,004 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -6.5% | 621 | $5K |
| Wells Fargo & Company | 0.00% | Reduce -6.8% | 300 | $2K |
| North Star Investment Management Corp. | 0.00% | No change | 250 | $2K |
| BNP Paribas Financial Markets | 0.00% | No change | 182 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -47.7% | 150 | $1K |
| US Bancorp \de | 0.00% | New | 100 | $760 |
| UBS Group AG | 0.00% | No change | 100 | $760 |
| FMR LLC | 0.00% | New | 72 | $547 |
| Bank of America Corp. | 0.00% | New | 22 | $167 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 15 | $114 |
| Lindbrook Capital, LLC | 0.00% | No change | 15 | $114 |
| Nemes Rush Group LLC | 0.00% | No change | 3 | $23 |
"% of holder's portfolio" is ONCT's weight in each manager's 13F, not the share of Oncternal Therapeutics Inc. the manager owns.